Myovant Sciences Ltd. (MYOV)
Mar 10, 2023 - MYOV was delisted (reason: acquired by Sumitovant Biopharma)
26.98
0.00 (0.00%)
Last trade price
Stock Price Forecast
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MYOV stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '22 | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 2 | 2 | 2 | 2 | 2 |
| Buy | 6 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 10 | 10 | 10 | 10 | 10 |
Financial Forecast
Revenue This Year
427.93M
from 230.97M
Increased by
85.27%
Revenue Next Year
556.07M
from 427.93M
Increased by
29.94%
EPS This Year
-1.78
from -2.22
EPS Next Year
-0.93
from -1.78
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 59.32M | 230.97M | 427.93M | 556.07M | 701.44M | 1.08B | 1.52B | 1.59B |
| Revenue Growth | - | - | - | - | 289.39% | 85.27% | 29.94% | 26.14% | 54.25% | 40.85% | 4.53% |
| EPS | -2.41 | -4.09 | -3.37 | -2.83 | -2.22 | -1.78 | -0.93 | -0.54 | 0.96 | 2.35 | 1.73 |
| EPS Growth | - | - | - | - | - | - | - | - | - | 144.71% | -26.09% |
| No. Analysts | - | - | - | - | - | 7 | 7 | 5 | 5 | 3 | 3 |
Revenue Forecast
| Revenue | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| High | 456.4M | 752.0M | 868.1M | 1.2B | 1.6B | 1.6B |
| Avg | 427.9M | 556.1M | 701.4M | 1.1B | 1.5B | 1.6B |
| Low | 393.6M | 410.5M | 491.1M | 963.3M | 1.5B | 1.5B |
Revenue Growth
| Revenue Growth | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| High | 97.6%
| 75.7%
| 56.1%
| 73.6%
| 45.0%
| 7.6%
|
| Avg | 85.3%
| 29.9%
| 26.1%
| 54.3%
| 40.9%
| 4.5%
|
| Low | 70.4%
| -4.1%
| -11.7%
| 37.3%
| 35.3%
| 0.5%
|
EPS Forecast
| EPS | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| High | -1.56 | 0.50 | -0.11 | 1.90 | 2.42 | 1.79 |
| Avg | -1.78 | -0.93 | -0.54 | 0.96 | 2.35 | 1.73 |
| Low | -1.96 | -1.76 | -1.06 | -0.05 | 2.25 | 1.67 |
EPS Growth
| EPS Growth | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | 151.9%
| -23.9%
|
| Avg | - | - | - | - | 144.7%
| -26.1%
|
| Low | - | - | - | - | 135.1%
| -29.0%
|
Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.